Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-03
2008-12-16
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S083000, C546S080000, C546S062000, C544S126000, C544S333000, C544S361000, C514S291000, C514S285000, C514S256000, C514S253030, C514S232800
Reexamination Certificate
active
07465742
ABSTRACT:
This application relates to novel fused tricyclic thienopyridines of Formulas I and II, which useful for treating Hepatitis B infection and other diseases.This application also relates to pharmaceutical compositions comprising thienopyridines and to the use of such compositions to treat Hepatitis B and other diseases.
REFERENCES:
patent: 6964956 (2005-11-01), Cywin et al.
Chen Huanming
Raney Anneke K.
Tam Robert
Aulakh Charanjit S.
McDermott Will & Emery LLP
LandOfFree
Heterocyclic compounds having anti-HBV activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds having anti-HBV activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds having anti-HBV activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4034485